Patents by Inventor Kaspars TARS

Kaspars TARS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240207382
    Abstract: Provided is an immunogenic composition including a peptide, wherein consecutive amino acids of the peptide include at least amino acids 186-193 of SEQ ID NO:1 and one or more adjuvants. In an example, the peptide is covalently linked to an amino acid sequence including SEQ ID NO:2.
    Type: Application
    Filed: August 17, 2023
    Publication date: June 27, 2024
    Applicants: Health Research, Inc., Latvian Biomedical Research and Study Center
    Inventors: Yi-Pin LIN, Kaspars TARS
  • Publication number: 20240189407
    Abstract: The present invention relates to a modified virus-like particle of RNA bacteriophage AP205 (AP205 VLP) comprising AP205 coat protein dimers to which antigenic polypeptides are fused at the N-terminus and/or at the C-terminus. The modified AP205 VLPs can be used as a platform, in particular for vaccine development, in generating immune responses against a variety of antigens.
    Type: Application
    Filed: April 11, 2022
    Publication date: June 13, 2024
    Inventors: Kaspars TARS, Ilva LIEKNINA, Darja CERNOVA
  • Publication number: 20190209668
    Abstract: The present invention relates to compositions, immunogenic or vaccine compositions and pharmaceutical compositions for the prevention or treatment of canine atopic dermatitis (CAD). Furthermore, the invention provides methods for preventing or treating CAD. The compositions of the invention induce efficient immune responses, in particular antibody responses, in dogs and are, therefore, useful for the treatment and/or prevention of CAD.
    Type: Application
    Filed: April 26, 2017
    Publication date: July 11, 2019
    Inventor: Kaspars TARS
  • Publication number: 20190201516
    Abstract: Provided is an immunogenic composition including a peptide, wherein consecutive amino acids of the peptide include at least amino acids 186-193 of SEQ ID NO:1 and one or more adjuvants. In an example, the peptide is covalently linked to an amino acid sequence including SEQ ID NO:2.
    Type: Application
    Filed: December 21, 2018
    Publication date: July 4, 2019
    Applicant: Health Research, Inc.
    Inventors: Yi-Pin LIN, Kaspars TARS